Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04243447 · ClinicalTrials.gov registry record
Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery
A clinical trial of Femoracetabular Impingement, sponsored by Washington University School of Medicine.
- Active
- Registry status
- 747
- Enrollment target
- 13
- Study locations
NCT04243447: Active study of Femoracetabular Impingement, sponsored by Washington University School of Medicine.
NCT04243447 is a study of Femoracetabular Impingement that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 747 participants. The trial reports 13 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04243447, a study of Femoracetabular Impingement, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- 747 participants
- Enrollment target
- 13
- Study locations
Study Summary
The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.
Primary Outcome
HOOS is a questionnaire constructed to assess patient-relevant outcomes in five separate sub-scales (pain, symptoms, activity of daily living, sport and recreation function and hip-related quality of life). HOOS is scored 0-100 with higher scores being the best outcome.
Conditions Studied
Study Locations (13)
Minnesota
- Twin Cities Orthopedics - Edina
- Mayo Clinic - Rochester
Texas
- Scottish Rite Hospital for Children - Dallas
- San Antonio Military Medical Center - San Antonio
Ontario
- Children's Hospital of Eastern Ontario - Ottawa
- The Ottawa Hospital - Ottawa
Colorado
- University of Colorado - Aurora
Iowa
- University of Iowa - Iowa City
Massachusetts
- Boston Children's Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 747 participants |
| Start Date | 2020-02-02 |
| Est. Completion | 2025-11-29 |
What the registry record for NCT04243447 still lists
NCT04243447 is an observational study that tracks outcomes without assigning an intervention. The registered 747 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Femoracetabular Impingement appearing as the primary indexed condition, and to 0 interventions.
NCT04243447 lists 13 locations in 10 states (Minnesota, Texas, Ontario).
Frequently Asked Questions
What is clinical trial NCT04243447 about?
NCT04243447 is a clinical study titled "Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery". The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predicto...
What is the current status of trial NCT04243447?
This trial is currently active not recruiting. The enrollment target is 747 participants. The study started on 2020-02-02. Estimated completion is 2025-11-29.
What conditions does trial NCT04243447 study?
This clinical trial studies the following conditions: Femoracetabular Impingement.
Who is sponsoring clinical trial NCT04243447?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04243447 being conducted?
This trial has 13 study locations across Colorado, Iowa, Massachusetts, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoracetabular Impingement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI